Sanara MedTech (SMTI) Liabilities and Shareholders Equity (2010 - 2026)

Sanara MedTech has reported Liabilities and Shareholders Equity for 16 years, with the latest figure at $69.3 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 28.12% year-over-year to $69.3 million; the trailing twelve-month figure through Mar 2026 stood at $312.1 million (down 9.91% YoY), and the FY2025 full-year result was $72.9 million, down 17.2% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $69.3 million, down from $72.9 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $98.8 million in Q2 2025, with the low at $33.9 million in Q1 2022.
• Historically, Liabilities and Shareholders Equity has averaged $71.4 million across 5 years, with a median of $72.9 million in 2025.
• Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity soared 76.72% — and 2026, when it retreated 28.12%.
• Sanara MedTech's Liabilities and Shareholders Equity stood at $61.0 million in 2022, then rose by 21.03% to $73.9 million in 2023, then increased by 19.25% to $88.1 million in 2024, then fell by 17.2% to $72.9 million in 2025, then decreased by 5.03% to $69.3 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $69.3 million (Q1 2026), $72.9 million (Q4 2025), and $71.1 million (Q3 2025), per Business Quant data.